Multi-agency Information for Patients and Providers: e-Cigarette, or Vaping, Product Use Associated Lung Injury (EVALI)

Multi-agency Information for Patients and Providers: e-Cigarette, or Vaping, Product Use Associated Lung Injury (EVALI) Posted By:
...

By now, we have all heard the news concerning the dangers of e-cigarettes and vaping and have likely received a myriad of updates in our ever-growing e-mail inboxes. As a busy clinician and educator, I enjoy bringing quick references to our blog readers. If you are like me, you have just enough (or not enough) time to open and respond to only your most critical e-mails. With this in mind, I recently sent the CDC's EVALI Guidelineswhich are updated every weekto our faculty practice NPs.

With flu season upon us, we need to be cognizant of how similarly EVALI and the flu can present, as progression of EVALI is rapid, with a short window for intervention. Just to recap the news, the CDC has identified vitamin E acetate as a "chemical of concern" among those affected with EVALI. Additionally, the CDC recommends avoiding use of e-cigarette and vaping products that contain THC. The investigation is ongoing and will likely continue to evolve over the coming weeks and months, but the CDC confirmed the following statistics as of November 13, 2019: 2172 cases of EVALI from 49 states (exception: Alaska), Washington DC, and Puerto Rico and U.S. Virgin Islands; and 42 deaths in 24 states and Washington DC.

I would recommend printing the fact sheet for Evaluating and Caring for Patients with Suspected E-Cigarette, or Vaping, Product Use Associated Lung Injury (EVALI). This convenient resource provides clinical evaluation pearls including relevant history and physical, lab testing, and imaging recommendations, as well as treatment and follow-up guidance. There are additional resources available on the CDC's website. You can view some of them through the links in the references below. Consider linking them to your practice webpages or electronic media platforms.

References

Share

Filed under: Public Health , Pulmonary Medicine

Related
Doxy-PEP: A New Opportunity to Reduce STIs

Doxy-PEP: A New Opportunity to Reduce STIs

According to CDC data from 2022, more than 2.5 million cases of chlamydia, gonorrhea, and syphilis w ...

Filed under: Nurses Week, Infectious Diseases, Urology, Preventive Medicine, Public Health, Substance Abuse, NPs & PAs


Continue Reading
Guidance on Opioid Tapering

Guidance on Opioid Tapering

Within the United States, pain is the most common reason for adults to seek medical care within both ...

Filed under: Neurology, Psychiatry, Public Health, Substance Abuse, NPs & PAs


Continue Reading
Patient Education: Safe Use of Opioid Analgesics and Naloxone

Patient Education: Safe Use of Opioid Analgesics a ...

When providing patients with prescriptions of any type, it is best practice to also provide them wit ...

Filed under: Neurology, Psychiatry, Public Health, Substance Abuse, NPs & PAs


Continue Reading
Treatment of COVID-19: Practical Questions and Insights for NPs and PAs

Treatment of COVID-19: Practical Questions and Ins ...

Is it reasonable to prescribe a 5-day supply of an oral antiviral to people traveling abroad with ri ...

Filed under: Infectious Diseases, Public Health, NPs & PAs


Continue Reading
Assessment of COVID-19: Practical Questions and Insights for NPs and PAs

Assessment of COVID-19: Practical Questions and In ...

How long should people isolate when they test positive for COVID-19?The CDC recommends that one shou ...

Filed under: Infectious Diseases, Public Health, NPs & PAs


Continue Reading
Navigating Nonpharmacologic Approaches to Chronic Pain Management

Navigating Nonpharmacologic Approaches to Chronic ...

The concept of multimodal treatment in chronic pain management goes back to some of the early establ ...

Filed under: Psychiatry, Preventive Medicine, Public Health, Substance Abuse, NPs & PAs


Continue Reading